-
Vernakalant is a new investigational anti-arrhythmic drug. The compound is relatively selective, blocking the early-activating potassium channel and the frequency-dependent sodium channel; it has a half-life of two to three hours.
-
Pioglitazone and heart disease; ARBs manufacturers spend millions to show the non-inferiority of their products compared to less expensive, generic ACE inhibitors; some athletes turn to growth hormone because it is difficult to detect; FDA Actions
-
-
As reviewed in part i of this series, many important endogenous and exogenous factors adversely affect the quality of sleep for women after ovarian failure. In fact, the National Sleep Foundation reports that 61% of women complain of insomnia after ovarian failure.
-
The objective of this study was to assess the feasibility, safety, and efficacy of Ginkgo biloba extract (GBE) on delaying the progression to cognitive impairment in normal elderly subjects aged 85 and older.
-
The effect of socioeconomic status (SES) of women on complementary and alternative medicine (CAM) use is not uniform across racial/ethnic populations, researchers stated in a study published in the Winter 2008 issue of Ethnicity & Disease Journal.
-
-
Agaricus blazei murrill (abm), popularly known as "Cogumelo do Sol" in Brazil, or "Himematsutake" in Japan, is a mushroom native to Brazil, and widely cultivated in Japan for its medicinal uses, it is now considered one of the most important edible and culinary-medicinal biotechnological species.
-
Hospitals with major trauma units need pharmacists on hand to handle emergencies. But if there is a limited number of pharmacists who are trained and prepared to work in the intensive care unit (ICU) or emergency room then the hospital might come up short during a major crisis period.
-
It's time to take propoxyphene off the hospital's shelves, according to the recent clarion call issued by the American Society of Health-System Pharmacists (ASHP) of Bethesda, MD. ASHP called for the Food and Drug Administration (FDA) to remove the pain drug from the market.
